The price-to-earnings ratio for Sabra Healthcare REIT Inc (NASDAQ: SBRA) is above average at 77.47x. The 36-month beta value for SBRA is also noteworthy at 1.23. There are mixed opinions on the stock, with 3 analysts rating it as a “buy,” 1 rating it as “overweight,” 7 rating it as “hold,” and 1 rating it as “sell.”
The public float for SBRA is 230.41M, and at present, short sellers hold a 5.01% of that float. The average trading volume of SBRA on September 05, 2024 was 2.16M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SBRA) stock’s latest price update
Sabra Healthcare REIT Inc (NASDAQ: SBRA)’s stock price has surge by 1.76relation to previous closing price of 17.00. Nevertheless, the company has seen a 3.10% surge in its stock price over the last five trading sessions. businesswire.com reported 2024-08-27 that TUSTIN, Calif.–(BUSINESS WIRE)– #BAML–Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company’s Chair and Chief Executive Officer, Michael Costa, the company’s Chief Financial Officer, Talya Nevo-Hacohen, the company’s Chief Investment Officer, Darrin Smith, the company’s Executive Vice President of Investments, and Lukas Hartwich, the company’s Senior Vice President of Finance, will participate in the BofA Securities 2024 Global Real Estate Conference on September.
SBRA’s Market Performance
SBRA’s stock has risen by 3.10% in the past week, with a monthly rise of 7.99% and a quarterly rise of 18.49%. The volatility ratio for the week is 1.53% while the volatility levels for the last 30 days are 2.16% for Sabra Healthcare REIT Inc The simple moving average for the last 20 days is 4.84% for SBRA stock, with a simple moving average of 18.43% for the last 200 days.
Analysts’ Opinion of SBRA
Many brokerage firms have already submitted their reports for SBRA stocks, with Deutsche Bank repeating the rating for SBRA by listing it as a “Buy.” The predicted price for SBRA in the upcoming period, according to Deutsche Bank is $21 based on the research report published on January 30, 2024 of the current year 2024.
BMO Capital Markets, on the other hand, stated in their research note that they expect to see SBRA reach a price target of $16. The rating they have provided for SBRA stocks is “Market Perform” according to the report published on October 17th, 2023.
Wells Fargo gave a rating of “Equal Weight” to SBRA, setting the target price at $15 in the report published on October 16th of the previous year.
SBRA Trading at 7.29% from the 50-Day Moving Average
After a stumble in the market that brought SBRA to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 0.90% of gains for the given period.
Volatility was left at 2.16%, however, over the last 30 days, the volatility rate increased by 1.53%, as shares surge +4.98% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +15.64% upper at present.
During the last 5 trading sessions, SBRA rose by +3.10%, which changed the moving average for the period of 200-days by +19.56% in comparison to the 20-day moving average, which settled at $16.54. In addition, Sabra Healthcare REIT Inc saw 21.23% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SBRA starting from Cusack Catherine, who purchase 7,000 shares at the price of $14.43 back on May 22 ’24. After this action, Cusack Catherine now owns 46,385 shares of Sabra Healthcare REIT Inc, valued at $101,010 using the latest closing price.
FOSTER MICHAEL J, the Director of Sabra Healthcare REIT Inc, sale 10,000 shares at $14.68 during a trade that took place back on May 14 ’24, which means that FOSTER MICHAEL J is holding 63,923 shares at $146,830 based on the most recent closing price.
Stock Fundamentals for SBRA
Current profitability levels for the company are sitting at:
- 0.52 for the present operating margin
- 0.51 for the gross margin
The net margin for Sabra Healthcare REIT Inc stands at 0.08. The total capital return value is set at 0.07. Equity return is now at value 1.83, with 0.96 for asset returns.
Based on Sabra Healthcare REIT Inc (SBRA), the company’s capital structure generated 0.47 points at debt to capital in total, while cash flow to debt ratio is standing at 0.12. The debt to equity ratio resting at 0.89. The interest coverage ratio of the stock is 2.7.
Currently, EBITDA for the company is 418.15 million with net debt to EBITDA at 5.65. When we switch over and look at the enterprise to sales, we see a ratio of 9.59. The receivables turnover for the company is 1.28for trailing twelve months and the total asset turnover is 0.13.
Conclusion
In summary, Sabra Healthcare REIT Inc (SBRA) has had a better performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
